SMT201500131B - Composizione di inibizione virale per uso terapeutico in vivo - Google Patents
Composizione di inibizione virale per uso terapeutico in vivoInfo
- Publication number
- SMT201500131B SMT201500131B SM201500131T SM201500131T SMT201500131B SM T201500131 B SMT201500131 B SM T201500131B SM 201500131 T SM201500131 T SM 201500131T SM 201500131 T SM201500131 T SM 201500131T SM T201500131 B SMT201500131 B SM T201500131B
- Authority
- SM
- San Marino
- Prior art keywords
- vivo
- composition
- therapeutic use
- viral inhibition
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2011/054758 WO2011117424A1 (en) | 2010-03-26 | 2011-03-28 | Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component |
PCT/EP2011/066746 WO2012038553A1 (en) | 2011-03-28 | 2011-09-27 | Viral inhibitor composition for in vivo therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201500131B true SMT201500131B (it) | 2015-07-09 |
Family
ID=44677899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201500131T SMT201500131B (it) | 2011-03-28 | 2015-06-09 | Composizione di inibizione virale per uso terapeutico in vivo |
Country Status (26)
Country | Link |
---|---|
US (1) | US9315448B2 (ru) |
EP (1) | EP2691088B1 (ru) |
JP (1) | JP5701445B2 (ru) |
KR (1) | KR101818286B1 (ru) |
CN (1) | CN103458883B (ru) |
AU (1) | AU2011306879B2 (ru) |
BR (1) | BR112013024457A2 (ru) |
CA (1) | CA2830703C (ru) |
CO (1) | CO6771455A2 (ru) |
DK (1) | DK2691088T3 (ru) |
EA (1) | EA025610B1 (ru) |
ES (1) | ES2538011T3 (ru) |
HK (1) | HK1188715A1 (ru) |
HR (1) | HRP20150596T1 (ru) |
IL (1) | IL228444A (ru) |
MA (1) | MA34975B1 (ru) |
MX (1) | MX2013011242A (ru) |
NZ (1) | NZ615613A (ru) |
PL (1) | PL2691088T3 (ru) |
PT (1) | PT2691088E (ru) |
RS (1) | RS54022B1 (ru) |
SG (1) | SG193426A1 (ru) |
SI (1) | SI2691088T1 (ru) |
SM (1) | SMT201500131B (ru) |
UA (1) | UA110512C2 (ru) |
WO (1) | WO2012038553A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112280750B (zh) * | 2020-10-22 | 2022-11-01 | 山东农业大学 | 具有跨种传播能力的新型鹅星状病毒及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU78955A1 (de) | 1978-01-27 | 1979-09-06 | Chimicasa Gmbh | Verfahren zur inaktivierung von viren |
US4902678A (en) | 1982-02-12 | 1990-02-20 | Syntex (U.S.A.) Inc. | Anti-viral compositions |
US5128353A (en) * | 1985-06-20 | 1992-07-07 | University Of Florida | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
US5856364A (en) | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
WO2002056879A1 (en) | 2001-01-03 | 2002-07-25 | Medpharma Plc | Use of terpenes for the treatment of digestive tract infections |
US20040071757A1 (en) | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
-
2011
- 2011-09-27 KR KR1020137027360A patent/KR101818286B1/ko active IP Right Grant
- 2011-09-27 SI SI201130509T patent/SI2691088T1/sl unknown
- 2011-09-27 PT PT117610857T patent/PT2691088E/pt unknown
- 2011-09-27 PL PL11761085T patent/PL2691088T3/pl unknown
- 2011-09-27 EA EA201370181A patent/EA025610B1/ru unknown
- 2011-09-27 WO PCT/EP2011/066746 patent/WO2012038553A1/en active Application Filing
- 2011-09-27 UA UAA201311023A patent/UA110512C2/ru unknown
- 2011-09-27 CA CA2830703A patent/CA2830703C/en active Active
- 2011-09-27 CN CN201180069698.7A patent/CN103458883B/zh active Active
- 2011-09-27 DK DK11761085.7T patent/DK2691088T3/en active
- 2011-09-27 RS RS20150382A patent/RS54022B1/en unknown
- 2011-09-27 EP EP11761085.7A patent/EP2691088B1/en active Active
- 2011-09-27 AU AU2011306879A patent/AU2011306879B2/en active Active
- 2011-09-27 JP JP2014501454A patent/JP5701445B2/ja active Active
- 2011-09-27 MX MX2013011242A patent/MX2013011242A/es active IP Right Grant
- 2011-09-27 ES ES11761085.7T patent/ES2538011T3/es active Active
- 2011-09-27 MA MA36264A patent/MA34975B1/fr unknown
- 2011-09-27 BR BR112013024457-7A patent/BR112013024457A2/pt not_active Application Discontinuation
- 2011-09-27 SG SG2013068671A patent/SG193426A1/en unknown
- 2011-09-27 US US14/008,092 patent/US9315448B2/en active Active
- 2011-09-27 NZ NZ615613A patent/NZ615613A/en unknown
-
2013
- 2013-09-15 IL IL228444A patent/IL228444A/en active IP Right Grant
- 2013-09-25 CO CO13228235A patent/CO6771455A2/es unknown
-
2014
- 2014-02-24 HK HK14101759.3A patent/HK1188715A1/xx unknown
-
2015
- 2015-06-03 HR HRP20150596TT patent/HRP20150596T1/hr unknown
- 2015-06-09 SM SM201500131T patent/SMT201500131B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
SMT201500148B (it) | Composizioni per uso nel trattamento di infezioni virali | |
SMT201600079B (it) | Composizioni per somministrazione mirata di sirna | |
ZA201306926B (en) | Viral inhibitor composition for in vivo therapeutic use | |
SMT201600464B (it) | Procedimento per la preparazione di esterolo | |
EP2542074A4 (en) | PHARMACEUTICAL COMBINATION ACTIVE AGENTS AS HCV REPLICATION INHIBITORS | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
CO7020907A2 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos | |
CO6811815A2 (es) | Composiciones de nucleasa terapéuticas y métodos | |
IL270748B (en) | Preparations containing a substance with anticoxinic activity and their use to increase the activity of acetylcholinesterase inhibitors | |
EP2773342A4 (en) | COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | |
GB201110647D0 (en) | Delivery of viral agents | |
DK2714004T3 (da) | Peptidformuleringer med kontrolleret frigivelse | |
ZA201308541B (en) | Compounds for use in treatment of mucositis | |
SI2691083T1 (sl) | Farmacevtski sestavek sitagliptina | |
BR112014002830A2 (pt) | fotossensibilizador para uso terapêutico | |
BR112014005406A2 (pt) | composição de vacina e respectivo uso | |
PL3287131T3 (pl) | Terapeutyczne zastosowania ektoiny | |
IT1403282B1 (it) | Procedimento per la preparazione di linagliptin | |
BR112014000773A2 (pt) | composições de nicotinamida e uso terapêutico das mesmas | |
DK2583571T3 (da) | Forbedringer i forbindelse med skødeskind | |
BR112014010432A2 (pt) | uso médico | |
SMT201600301B (it) | USO TERAPEUTICO DELLA PROTEINAß2- MICROGLOBULINA | |
BR112013030930A2 (pt) | composições farmacêuticas combinadas para o tratamento de tumores | |
SMT201600416B (it) | Uso di sali di 3-carbossi-n-etil-n,n-dimetilpropan-1-amminio nel trattamento di malattie cardiovascolari |